174 related articles for article (PubMed ID: 21118508)
1. Recurrence and mortality according to estrogen receptor status for breast cancer patients undergoing conservative surgery. Ipsilateral breast tumour recurrence dynamics provides clues for tumour biology within the residual breast.
Demicheli R; Ardoino I; Boracchi P; Coradini D; Agresti R; Ferraris C; Gennaro M; Hrushesky WJ; Biganzoli E
BMC Cancer; 2010 Nov; 10():656. PubMed ID: 21118508
[TBL] [Abstract][Full Text] [Related]
2. Recurrence and mortality dynamics for breast cancer patients undergoing mastectomy according to estrogen receptor status: different mortality but similar recurrence.
Demicheli R; Biganzoli E; Ardoino I; Boracchi P; Coradini D; Greco M; Moliterni A; Zambetti M; Valagussa P; Gukas ID; Bonadonna G
Cancer Sci; 2010 Mar; 101(3):826-30. PubMed ID: 20132222
[TBL] [Abstract][Full Text] [Related]
3. Dynamics of the hazard for distant metastases after ipsilateral breast tumor recurrence according to estrogen receptor status: An analysis of 2851 patients.
Gennaro M; Di Cosimo S; Ardoino I; Veneroni S; Mariani L; Agresti R; Daidone MG; de Braud F; Apolone G; Biganzoli E; Demicheli R
Breast; 2018 Aug; 40():131-135. PubMed ID: 29772517
[TBL] [Abstract][Full Text] [Related]
4. Impact of screening and risk factors for local recurrence and survival after conservative surgery and radiotherapy for early breast cancer: results from a large series with long-term follow-up.
Kunkler IH; Kerr GR; Thomas JS; Jack WJ; Bartlett JM; Pedersen HC; Cameron DA; Dixon JM; Chetty U;
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):829-38. PubMed ID: 22197227
[TBL] [Abstract][Full Text] [Related]
5. Ipsilateral breast tumour recurrence (IBTR) dynamics in breast conserving treatments with or without radiotherapy.
Demicheli R; Ardoino I; Boracchi P; Lozza L; Biganzoli E
Int J Radiat Biol; 2010 Jul; 86(7):542-7. PubMed ID: 20545574
[TBL] [Abstract][Full Text] [Related]
6. Accelerated partial breast irradiation with interstitial brachytherapy as second conservative treatment for ipsilateral breast tumour recurrence: multicentric study of the GEC-ESTRO Breast Cancer Working Group.
Hannoun-Levi JM; Resch A; Gal J; Kauer-Dorner D; Strnad V; Niehoff P; Loessl K; Kovács G; Van Limbergen E; Polgár C;
Radiother Oncol; 2013 Aug; 108(2):226-31. PubMed ID: 23647758
[TBL] [Abstract][Full Text] [Related]
7. Is Multifocal Regression a Risk Factor for Ipsilateral Breast Tumor Recurrence in the Modern Era After Neoadjuvant Chemotherapy and Breast Conservation Therapy?
Ling DC; Sutera PA; Iarrobino NA; Diego EJ; Soran A; Johnson RR; Bhargava R; Champ CE; Beriwal S
Int J Radiat Oncol Biol Phys; 2019 Jul; 104(4):869-876. PubMed ID: 30885777
[TBL] [Abstract][Full Text] [Related]
8. [Evidence-based radiotherapy in the treatment of early-stage invasive breast cancer: traditional clinical features and biomarkers].
Fodor J
Magy Onkol; 2009 Mar; 53(1):7-14. PubMed ID: 19318321
[TBL] [Abstract][Full Text] [Related]
9. [Clinical characteristics and prognosis of patients with ipsilateral breast tumor recurrence after breast conservation therapy].
Sun GY; Wang SL; Tang Y; Jin J; Song YW; Liu YP; Wang WH; Fang H; Chen SY; Ren H; Liu XF; Yu ZH; Li YX
Zhonghua Zhong Liu Za Zhi; 2018 May; 40(5):352-358. PubMed ID: 29860762
[No Abstract] [Full Text] [Related]
10. Change in estrogen receptor, HER2, and Ki-67 status between primary breast cancer and ipsilateral breast cancer tumor recurrence.
Okumura Y; Nishimura R; Nakatsukasa K; Yoshida A; Masuda N; Tanabe M; Shien T; Tanaka S; Arima N; Komoike Y; Taguchi T; Iwase T; Inaji H; Ishitobi M;
Eur J Surg Oncol; 2015 Apr; 41(4):548-52. PubMed ID: 25682910
[TBL] [Abstract][Full Text] [Related]
11. Primary chemotherapy for operable breast cancer: incidence and prognostic significance of ipsilateral breast tumor recurrence after breast-conserving surgery.
Rouzier R; Extra JM; Carton M; Falcou MC; Vincent-Salomon A; Fourquet A; Pouillart P; Bourstyn E
J Clin Oncol; 2001 Sep; 19(18):3828-35. PubMed ID: 11559720
[TBL] [Abstract][Full Text] [Related]
12. Predictors of time to death after distant recurrence in breast cancer patients.
Sopik V; Sun P; Narod SA
Breast Cancer Res Treat; 2019 Jan; 173(2):465-474. PubMed ID: 30328050
[TBL] [Abstract][Full Text] [Related]
13. Ipsilateral breast tumor recurrence (IBTR) in patients with operable breast cancer who undergo breast-conserving treatment after receiving neoadjuvant chemotherapy: risk factors of IBTR and validation of the MD Anderson Prognostic Index.
Ishitobi M; Ohsumi S; Inaji H; Ohno S; Shigematsu H; Akiyama F; Iwase T; Akashi-Tanaka S; Sato N; Takahashi K; Oura S
Cancer; 2012 Sep; 118(18):4385-93. PubMed ID: 22252882
[TBL] [Abstract][Full Text] [Related]
14. Distant metastasis dynamics following subsequent surgeries after primary breast cancer removal.
Demicheli R; Dillekås H; Straume O; Biganzoli E
Breast Cancer Res; 2019 May; 21(1):57. PubMed ID: 31046808
[TBL] [Abstract][Full Text] [Related]
15. Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS.
Wapnir IL; Dignam JJ; Fisher B; Mamounas EP; Anderson SJ; Julian TB; Land SR; Margolese RG; Swain SM; Costantino JP; Wolmark N
J Natl Cancer Inst; 2011 Mar; 103(6):478-88. PubMed ID: 21398619
[TBL] [Abstract][Full Text] [Related]
16. Recurrence dynamics does not depend on the recurrence site.
Demicheli R; Biganzoli E; Boracchi P; Greco M; Retsky MW
Breast Cancer Res; 2008; 10(5):R83. PubMed ID: 18844974
[TBL] [Abstract][Full Text] [Related]
17. Patients with early stage invasive cancer with close or positive margins treated with conservative surgery and radiation have an increased risk of breast recurrence that is delayed by adjuvant systemic therapy.
Freedman G; Fowble B; Hanlon A; Nicolaou N; Fein D; Hoffman J; Sigurdson E; Boraas M; Goldstein L
Int J Radiat Oncol Biol Phys; 1999 Jul; 44(5):1005-15. PubMed ID: 10421533
[TBL] [Abstract][Full Text] [Related]
18. Local recurrence risk after previous salvage mastectomy.
Tanabe M; Iwase T; Okumura Y; Yoshida A; Masuda N; Nakatsukasa K; Shien T; Tanaka S; Komoike Y; Taguchi T; Arima N; Nishimura R; Inaji H; Ishitobi M;
Eur J Surg Oncol; 2016 Jul; 42(7):980-5. PubMed ID: 27055945
[TBL] [Abstract][Full Text] [Related]
19. Factors predicting in-breast tumor recurrence after breast-conserving surgery.
Mechera R; Viehl CT; Oertli D
Breast Cancer Res Treat; 2009 Jul; 116(1):171-7. PubMed ID: 18815880
[TBL] [Abstract][Full Text] [Related]
20. Intraoperative radiotherapy versus external radiotherapy for early breast cancer (ELIOT): a randomised controlled equivalence trial.
Veronesi U; Orecchia R; Maisonneuve P; Viale G; Rotmensz N; Sangalli C; Luini A; Veronesi P; Galimberti V; Zurrida S; Leonardi MC; Lazzari R; Cattani F; Gentilini O; Intra M; Caldarella P; Ballardini B
Lancet Oncol; 2013 Dec; 14(13):1269-77. PubMed ID: 24225155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
